CDK2 and non-small cell lung carcinoma: In this study, we have found that USP52 overexpression in NSCLC cell lines could inhibit CCND1 and CDK2 expression, which suggested that USP52 suppresses NSCLC through the mechanism of inhibits the expression of cell cycle regulatory proteins of CCND1 and CDK2.